{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:43:40Z","timestamp":1782873820167,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32372580"],"award-info":[{"award-number":["32372580"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFE0108400"],"award-info":[{"award-number":["2022YFE0108400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ijbiomac.2024.136403","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T13:56:11Z","timestamp":1728482171000},"page":"136403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P2","title":["Identification of a potent SARS-CoV-2 neutralizing nanobody targeting the receptor-binding domain of the spike protein"],"prefix":"10.1016","volume":"281","author":[{"given":"Chen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadiatullah","family":"Hadiatullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Yuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7798","key":"10.1016\/j.ijbiomac.2024.136403_bb0005","first-page":"270","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020"},{"issue":"6575","key":"10.1016\/j.ijbiomac.2024.136403_bb0010","first-page":"1586","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.136403_bb0015","first-page":"716","article-title":"An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron","volume":"7","author":"Quan","year":"2022"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.136403_bb0020","first-page":"894","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020"},{"issue":"7807","key":"10.1016\/j.ijbiomac.2024.136403_bb0025","first-page":"215","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020"},{"issue":"6483","key":"10.1016\/j.ijbiomac.2024.136403_bb0030","first-page":"1260","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020"},{"issue":"7819","key":"10.1016\/j.ijbiomac.2024.136403_bb0035","first-page":"115","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"Ju","year":"2020"},{"key":"10.1016\/j.ijbiomac.2024.136403_bb0040","article-title":"SARS-CoV-2 monoclonal antibodies with therapeutic potential: Broad neutralizing activity and No evidence of antibody-dependent enhancement","volume":"195","author":"Wang","year":"2021"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136403_bb0045","first-page":"6097","article-title":"COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models","volume":"12","author":"Maisonnasse","year":"2021"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.136403_bb0050","first-page":"1284","volume":"182","author":"Li","year":"2020","journal-title":"The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity"},{"issue":"6428","key":"10.1016\/j.ijbiomac.2024.136403_bb0055","first-page":"446","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993"},{"issue":"6518","key":"10.1016\/j.ijbiomac.2024.136403_bb0060","first-page":"168","article-title":"A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks","volume":"374","author":"Greenberg","year":"1995"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.136403_bb0065","first-page":"316","article-title":"Single-domain antibodies or nanobodies: a class of next-generation antibodies","volume":"37","author":"Khodabakhsh","year":"2018"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136403_bb0070","first-page":"1","article-title":"Single-domain antibodies and their formatting to combat viral infections","volume":"8","author":"De Vlieger","year":"2018"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136403_bb0075","first-page":"1970","article-title":"Dual beneficial effect of interloop disulfide bond for single domain antibody fragments","volume":"287","author":"Govaert","year":"2012"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.136403_bb0080","first-page":"695","article-title":"Biology, Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP\/PS1 mice but does not increase brain uptake","volume":"42","author":"Rotman","year":"2015"},{"issue":"24","key":"10.1016\/j.ijbiomac.2024.136403_bb0085","first-page":"12069","article-title":"Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120","volume":"82","author":"Forsman","year":"2008"},{"key":"10.1016\/j.ijbiomac.2024.136403_bb0090","first-page":"1639","article-title":"Caplacizumab: first global approval","volume":"78","author":"Duggan","year":"2018"},{"key":"10.1016\/j.ijbiomac.2024.136403_bb0095","first-page":"47","article-title":"Therapeutics, Nanobodies\u00ae as inhaled biotherapeutics for lung diseases","volume":"169","author":"Van Heeke","year":"2017"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.136403_bb0100","first-page":"891","volume":"27","author":"Wu","year":"2020","journal-title":"Microbe, identification of human single-domain antibodies against SARS-CoV-2"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.136403_bb0105","first-page":"846","article-title":"M. biology, Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2","volume":"27","author":"Huo","year":"2020"},{"key":"10.1016\/j.ijbiomac.2024.136403_bb0110","doi-asserted-by":"crossref","first-page":"105820","DOI":"10.1016\/j.antiviral.2024.105820","article-title":"Therapeutic antibodies and alternative formats against SARS-CoV-2","volume":"223","author":"Winiger","year":"2024","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136403_bb0115","first-page":"5469","article-title":"A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19","volume":"12","author":"Huo","year":"2021"},{"key":"10.1016\/j.ijbiomac.2024.136403_bb0120","article-title":"Structural characterization of a neutralizing nanobody with broad activity against SARS-CoV-2 variants","volume":"13","author":"Li","year":"2022"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.136403_bb0125","article-title":"Nasal delivery of single-domain antibody improves symptoms of SARS-CoV-2 infection in an animal model","volume":"17","author":"Haga","year":"2021"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136403_bb0130","first-page":"411","article-title":"A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA. 1 through a unique binding mode","volume":"20","author":"Zhao","year":"2022"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136403_bb0135","first-page":"568","article-title":"XDSAPP: a graphical user interface for the convenient processing of diffraction data using XDS","volume":"45","author":"Krug","year":"2012"},{"key":"10.1016\/j.ijbiomac.2024.136403_bb0140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.136403_bb0145","first-page":"2126","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004"},{"issue":"13","key":"10.1016\/j.ijbiomac.2024.136403_bb0150","first-page":"1605","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004"},{"issue":"6485","key":"10.1016\/j.ijbiomac.2024.136403_bb0155","first-page":"1444","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302407212X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302407212X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:47:17Z","timestamp":1782870437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302407212X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":31,"alternative-id":["S014181302407212X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136403","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a potent SARS-CoV-2 neutralizing nanobody targeting the receptor-binding domain of the spike protein","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"136403"}}